HELX
Exchange-traded product on NYSE (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Jun 30, 2026
The full portfolio as of the quarter end Jun 30, 2026, from the fund's report to the SEC (Form N-PORT, filed Aug 27, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Mar 31, 2026.
63 lines, 60 linked, weights sum to 98.73% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | GH US40131M1099 | Equity | 16,927 | +1,209 | 9.09% | $ 2.54M |
| NATERA INC | NTRA US6323071042 | Equity | 7,679 | +548 | 7.46% | $ 2.084M |
| KRYSTAL BIOTECH INC | KRYS US5011471027 | Equity | 4,757 | +339 | 6.33% | $ 1.768M |
| LIGAND PHARMACEUTICALS INC | LGND US53220K5048 | Equity | 4,085 | +291 | 4.62% | $ 1.291M |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT US00650F1093 | Equity | 51,956 | +3,711 | 3.99% | $ 1.114M |
| UNITED THERAPEUTICS CORP | UTHR US91307C1027 | Equity | 1,809 | +129 | 3.51% | $ 980.17K |
| BRIDGEBIO PHARMA INC | BBIO US10806X1028 | Equity | 13,129 | +937 | 3.50% | $ 977.848K |
| ELI LILLY & COMPANY | LLY US5324571083 | Equity | 688 | +95 | 2.95% | $ 825.208K |
| TWIST BIOSCIENCE CORP | TWST US90184D1000 | Equity | 7,736 | +552 | 2.85% | $ 795.88K |
| VERTEX PHARMACEUTICALS INC | VRTX US92532F1003 | Equity | 1,545 | +110 | 2.75% | $ 767.448K |
| ASTRAZENECA PLC | AZN GB0009895292 | Equity | 3,979 | +284 | 2.70% | $ 754.498K |
| TRAVERE THERAPEUTICS INC | TVTX US89422G1076 | Equity | 12,753 | +2,624 | 2.59% | $ 724.498K |
| INSMED INC | INSM US4576693075 | Equity | 6,388 | +456 | 2.44% | $ 681.089K |
| SAMSUNG BIOLOGICS CO LTD | 207940 KR7207940008 | Equity | 702 | +50 | 2.26% | $ 630.273K |
| CORTEVA INC | CTVA US22052L1044 | Equity | 7,435 | +531 | 2.25% | $ 629.67K |
| MEDPACE HOLDINGS INC | MEDP US58506Q1094 | Equity | 1,133 | −194 | 2.15% | $ 600.025K |
| ALNYLAM PHARMACEUTICALS INC | ALNY US02043Q1076 | Equity | 1,816 | +129 | 1.96% | $ 546.67K |
| TEMPUS AI INC | TEM US88023B1035 | Equity | 9,397 | +671 | 1.95% | $ 544.368K |
| IONIS PHARMACEUTICALS INC | IONS US4622221004 | Equity | 6,739 | +782 | 1.91% | $ 534.335K |
| NEUROCRINE BIOSCIENCES INC | NBIX US64125C1099 | Equity | 3,058 | +365 | 1.84% | $ 515.38K |
| REGENERON PHARMACEUTICALS INC | REGN US75886F1075 | Equity | 805 | +57 | 1.80% | $ 501.95K |
| VERACYTE INC | VCYT US92337F1075 | Equity | 7,819 | +1,031 | 1.64% | $ 459.21K |
| ARGENX SE | ARGX NL0010832176 | Equity | 494 | +35 | 1.64% | $ 458.271K |
| PTC THERAPEUTICS INC | PTCT US69366J2006 | Equity | 5,009 | +357 | 1.46% | $ 408.584K |
| BIONTECH SE | BNTX US09075V1026 | Equity | 4,156 | −184 | 1.38% | $ 386.716K |
| STOKE THERAPEUTICS INC | STOK US86150R1077 | Equity | 11,349 | +810 | 1.33% | $ 371.339K |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | CRL US1598641074 | Equity | 1,556 | +111 | 1.26% | $ 352.885K |
| GRAIL INC | GRAL US3847471014 | Equity | 4,456 | +318 | 1.09% | $ 304.211K |
| ANAPTYSBIO INC | ANAB US0327241065 | Equity | 4,290 | +2,249 | 1.04% | $ 289.575K |
| CRISPR THERAPEUTICS AG | CRSP CH0334081137 | Equity | 5,030 | +359 | 0.98% | $ 274.336K |
| REPLIGEN CORP | RGEN US7599161095 | Equity | 2,009 | +143 | 0.98% | $ 274.108K |
| CADENCE DESIGN SYSTEMS INC | CDNS US1273871087 | Equity | 725 | +180 | 0.97% | $ 272.107K |
| BEAM THERAPEUTICS INC | BEAM US07373V1052 | Equity | 7,577 | +541 | 0.93% | $ 260.043K |
| PRAXIS PRECISION MEDICINES INC | PRAX US74006W2070 | Equity | 718 | +51 | 0.86% | $ 240.379K |
| SARTORIUS AG | SRT3 DE0007165631 | Preferred | 905 | +64 | 0.85% | $ 237.564K |
| AXSOME THERAPEUTICS INC | AXSM US05464T1043 | Equity | 936 | +370 | 0.82% | $ 229.105K |
| CAREDX INC | CDNA US14167L1035 | Equity | 8,000 | +571 | 0.82% | $ 228K |
| JAZZ PHARMACEUTICALS PLC | JAZZ IE00B4Q5ZN47 | Equity | 905 | +64 | 0.78% | $ 218.078K |
|
CATALYST PHARMACEUTICALS INC
|
CPRX US14888U1016 | Equity | 6,865 | +490 | 0.77% | $ 215.767K |
| THERMO FISHER SCIENTIFIC INC | TMO US8835561023 | Equity | 421 | +30 | 0.76% | $ 211.073K |
| IQVIA HOLDINGS INC | IQV US46266C1053 | Equity | 1,082 | +77 | 0.75% | $ 209.064K |
| HINGE HEALTH INC | HNGE US4333131039 | Equity | 2,349 | +167 | 0.70% | $ 194.967K |
| ULTRAGENYX PHARMACEUTICAL INC | RARE US90400D1081 | Equity | 5,131 | +366 | 0.61% | $ 171.324K |
| AGILENT TECHNOLOGIES INC | A US00846U1016 | Equity | 1,223 | +87 | 0.58% | $ 162.451K |
| DANAHER CORP | DHR US2358511028 | Equity | 842 | −208 | 0.57% | $ 160.384K |
| QIAGEN NV | QGEN NL0015002SN0 | Equity | 3,419 | +244 | 0.48% | $ 133.683K |
| RHYTHM PHARMACEUTICALS INC | RYTM US76243J1051 | Equity | 1,048 | +74 | 0.42% | $ 116.359K |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT US03969K1088 | Equity | 4,422 | +315 | 0.42% | $ 115.945K |
| SAMSUNG EPIS HOLDINGS CO LTD | 0126Z0 KR70126Z0002 | Equity | 376 | +26 | 0.37% | $ 104.357K |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | KNSA GB00BRXB0C07 | Equity | 1,479 | new +1,479 | 0.34% | $ 94.582K |
| TARSUS PHARMACEUTICALS INC | TARS US87650L1035 | Equity | 1,136 | −351 | 0.26% | $ 71.5K |
| BIO-RAD LABORATORIES INC | BIO US0905722072 | Equity | 243 | +17 | 0.26% | $ 71.347K |
| LIQUIDIA CORP | LQDA US53635D2027 | Equity | 871 | new +871 | 0.25% | $ 69.445K |
| BRISTOL-MYERS SQUIBB COMPANY | BMY US1101221083 | Equity | 1,196 | +85 | 0.25% | $ 68.914K |
| TG THERAPEUTICS INC | TGTX US88322Q1085 | Equity | 1,253 | new +1,253 | 0.25% | $ 68.84K |
| BEONE MEDICINES LTD | ONC US07725L1026 | Equity | 225 | +16 | 0.23% | $ 64.118K |
| NEUROGENE INC | NGNE US64135M1053 | Equity | 1,981 | +141 | 0.22% | $ 62.302K |
| FIRST TRACKS BIOTHERAPEUTICS INC | TRAX US3371851029 | Equity | 2,775 | new +2,775 | 0.20% | $ 55.833K |
| GENEDX HOLDINGS CORP | WGS US81663L2007 | Equity | 575 | −834 | 0.14% | $ 39.474K |
| WAVE LIFE SCIENCES LTD | WVE SG9999014716 | Equity | 4,813 | +343 | 0.10% | $ 27.964K |
| RECURSION PHARMACEUTICALS INC | RXRX US75629V1044 | Equity | 5,507 | −4,886 | 0.07% | $ 20.211K |
|
OMNIAB INC
|
2200963D US68218J2024 | Equity | 240 | 0 | 0.00% | $ 0.00 |
|
OMNIAB INC
|
2200964D US68218J3014 | Equity | 240 | 0 | 0.00% | $ 0.00 |